BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/24/2022 10:35:19 AM | Browse: 487 | Download: 1121
 |
Received |
|
2021-12-09 17:56 |
|
Peer-Review Started |
|
2021-12-09 17:59 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-02-15 00:15 |
|
Revised |
|
2022-02-28 17:46 |
|
Second Decision |
|
2022-04-08 02:16 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-04-09 19:07 |
|
Articles in Press |
|
2022-04-09 19:07 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-05-07 02:22 |
|
Publish the Manuscript Online |
|
2022-05-24 10:35 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Nicole Cianci, Mohsan Subhani, Trevor Hill, Amardeep Khanna, Dong Zheng, Abhishek Sheth, Colin Crooks and Guruprasad P Aithal |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nicole Cianci, MBBS, Academic Fellow, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust and University of Oxford, NA, Oxford OX3 9DU, United Kingdom. nicolecianci95@gmail.com |
| Key Words |
Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Biomarkers; Non-invasive; Prognosis; Mortality |
| Core Tip |
Non-alcoholic fatty liver disease (NAFLD) represents a growing public health concern, with an estimated prevalence in European general populations of 20%-40% and epidemiological projections of significant future increase in prevalence. NAFLD patients are at increased risk of morbidity and mortality, so it’s important to validate non-invasive prognostic markers for predicting mortality in NAFLD. This systematic review highlighted several non-invasive prognostic markers including biomarkers and imaging modalities. This meta-analysis showed that NAFLD fibrosis score is a useful prognostic marker for all-cause and cardiovascular mortality, which can be implemented in clinical practice to risk stratify and target high risk NAFLD patients. |
| Publish Date |
2022-05-24 10:35 |
| Citation |
Cianci N, Subhani M, Hill T, Khanna A, Zheng D, Sheth A, Crooks C, Aithal GP. Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis. World J Hepatol 2022; 14(5): 1025-1037 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i5/1025.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i5.1025 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
